Profiles of Nicotine and Cannabis Exposure among Young adults with asthma.

Introduction:
This article provides an in-depth analysis of the regulatory landscape for digital health companies in the United States. The text covers the various laws, regulations, and guidance documents that impact digital health companies, including those related to data privacy, security, and quality. The reader will gain a comprehensive understanding of the legal and regulatory requirements for digital health companies operating in the US.

Key Points:

* The Food and Drug administration (FDa) is the primary regulator of digital health products in the US.
* The Federal Trade Commission (FTC) has jurisdiction over advertising and marketing practices for digital health companies.
* The health Insurance Portability and accountability act (hIPaa) sets privacy and security standards for protected health information.
* The 21st Century Cures act includes provisions related to digital health, including the creation of the FDa's Digital health Software Precertification Program.
* Digital health companies must comply with state-specific laws and regulations related to data privacy and security.
* The quality Payment Program (qPP) established by the Medicare access and ChIP Reauthorization act of 2015 (MaCRa) includes provisions related to digital health.
* Digital health companies should consider seeking legal advice to ensure compliance with all applicable laws and regulations.

Main Message:
Digital health companies face a complex regulatory landscape in the United States. Compliance with laws and regulations related to data privacy, security, and quality is essential for these companies to operate legally and maintain the trust of their customers. Seeking legal advice can help digital health companies navigate this landscape and ensure compliance with all applicable laws and regulations. It is crucial for digital health companies to prioritize regulatory compliance to protect their customers and ensure long-term success.

Clawson ah, Ruppe NM, Nwankwo CN, Blair aL. Profiles of Nicotine and Cannabis Exposure among Young adults with asthma. Behavioral medicine (Washington, DC). 2022;48(1):18-30. doi:10.1080/08964289.2020.1763904